Care After Lymphoma (CALy) Trial: A phase II pilot randomised controlled trial of a lymphoma nurse-led model of survivorship care
- Conditions
- ymphomaInformational and practical needsDepressionAnxietyStressSelf-empowermentLymphomaCancer - Hodgkin'sCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma
- Registration Number
- ACTRN12615000530527
- Lead Sponsor
- niversity of Notre Dame Australia, Fremantle Campus
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Able to understand, read and write English
Pathologically confirmed new diagnosis of Hodgkin or non-Hodgkin lymphoma
Completed first line curative intent chemotherapy treatment or second line curative intent autologous transplant within the previous three months
No evidence of lymphoma on PET scan
Diagnosis of other haematological malignancy
Did not undergo chemotherapy treatment
Further treatment or follow-up at another hospital
Undergoing active treatment
Acute mental health condition that will preclude informed consent
Intellectually disabled
Comorbid condition that requires at least monthly visits with genral practitioner (GP)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method